Search results
Ranbaxy Laboratories Limited was an Indian multinational pharmaceutical company that was incorporated in India in 1961 and remained an entity until 2014. The company went public in 1973. Ownership of Ranbaxy changed twice over the course of its history.
Sun Pharma completed the acquisition of Ranbaxy Laboratories Limited, an integrated, research based, international pharmaceutical company, on 25th March 2015. Information and announcements about this can be found on this page.
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company, producing a wide range of quality, affordable generic...
Sun Pharma offers a program for individuals who want to disclose violations of US FDA requirements related to facilities owned or operated by Ranbaxy or products owned by Ranbaxy prior to Sun Pharma’s acquisition of Ranbaxy.
Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) and Ranbaxy Laboratories Ltd (Reuters: RANB.BO, Bloomberg: RBXY IN, NSE: RANBAXY, BSE: 500359) today announced that they have entered into definitive agreements pursuant to which Sun Pharma will acquire 100% of Ranbaxy in an all-stock transaction.
Oct 11, 2019 · WHAT HAPPENED TO RANBAXY? They sold it. In 2008, when Ranbaxy was at its peak, Malvinder and Shivinder Singh sold their controlling stake to the Japanese pharma giant Daiichi Sankyo. The Ranbaxy sale earned the brothers a windfall amount of Rs 9,576 crore.
Apr 7, 2014 · Sun Pharmaceutical Industries Ltd is buying Ranbaxy Laboratories Ltd through an all-stock merger in which five shares of Ranbaxy will fetch four shares of Sun Pharma. Based on their closing...
Apr 1, 2015 · Ranbaxy Laboratories Ltd. is pharmaceutical company. It develops, manufactures and markets generic, branded generic, over-the-counter products, anti-retrovirals, active pharmaceutical...
5 days ago · Ranbaxy Laboratories Limited Stock Price Today, Live NSE Share Price: Get the latest Ranbaxy Laboratories Limited news, company updates, quotes, tips, historical charts, 52 week high low, market performance financial reports and many more at NSE India.
Ranbaxy's sales had by then topped the $1 billion mark, placing the company not only as the leader in India's pharmaceuticals industry, but also among the ranks of the world's top 100 pharmaceuticals companies. Ranbaxy also boasted a place among the world's top ten generic drugs producers.
